2-Fluorophenylboronic acid → HCID 86679876, compound

HRID 1519386Notes

Reaction equation

HRID 1519386 reaction equation
C[O:2][C:3](=[O:24])[C:4]1[CH:9]=[C:8]([C:10]2[S:11][CH:12]=[C:13]([C:15]3[CH:20]=[CH:19][C:18]([Cl:21])=[C:17]([Cl:22])[CH:16]=3)[N:14]=2)[CH:7]=[CH:6][C:5]=1Br.[F:25][C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=1B(O)O>>[Cl:22][C:17]1[CH:16]=[C:15]([C:13]2[N:14]=[C:10]([C:8]3[CH:9]=[C:4]([C:3]([OH:2])=[O:24])[C:5]([C:27]4[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=4[F:25])=[CH:6][CH:7]=3)[S:11][CH:12]=2)[CH:20]=[CH:19][C:18]=1[Cl:21]

Participants

3

Reactant 2

HCID 27343542-Fluorophenylboronic acidHCID 86679833Methyl 2-bromo-5-(4-(3,4-dichlorophenyl)thiazol-2-yl)benzoate2×

Product 1

HCID 86679876HCID 86679876, compoundYield 34%

Procedure

Using the conditions of General Procedure B for Suzuki Coupling and Hydrolysis in Parallel Mode, 2-bromo-5-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-benzoic acid methyl ester (which may be prepared as described for Intermediate 6; 89 mg, 0.2 mmol) was reacted with 2-fluorophenylboronic acid (available from Combi-Blocks Inc.; 56 mg, 0.4 mmol). The resulting ester was hydrolyzed and the acid was purified to give 4-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-2′-fluoro-biphenyl-2-carboxylic acid (30 mg, 34%). 1H NMR (400 MHz, DMSO-d6) δ 13.11 (br s, 1H), 8.48 (s, 2H), 8.34 (s, 1H), 8.28 (d, J=7.8 Hz, 1H), 8.09 (d, J=8.3 Hz, 1H), 7.77 (d, J=6.5 Hz, 1H), 7.56 (d, J=6.5 Hz, 1H), 7.39-7.48 (m, 2H), 7.20-7.35 (m, 2H).

Workup

  1. customthe acid was purified

Sources & evidence

ORD record
ord-176ae8aae99d4e25bb8f704017a03b43
Source dataset
uspto-grants-2015_07
Patent number
US09073881B2

Reaction notes

Loading…